Toward beta cell replacement for diabetes

No abstract is available for this paper.

• Publication year

  2015

• Venue

  EMBO Journal

• Publication date

  2015-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.15252/embj.201490685PMID 25733347PMCID PMC4388595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AN IN VITRO

  2016cited by this paper
• Reprint of: Extracellular matrix as a biological scaffold material: Structure and function.

  2015cited by this paper
• De Novo Formation of Insulin-Producing “Neo-β Cell Islets” from Intestinal Crypts

  2014cited by this paper
• Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus

  2014cited by this paper
• Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

  2014cited by this paper
• Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

  2014influential reference
• Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes

  2014cited by this paper
• Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges

  2014cited by this paper
• FOXO1 Inhibition Yields Functional Insulin-Producing Cells In Human Gut Organoid Cultures

  2014cited by this paper
• Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells

  2014influential reference
• β-Cell Dysfunction Due to Increased ER Stress in a Stem Cell Model of Wolfram Syndrome

  2014influential reference
• A guide to genome engineering with programmable nucleases

  2014cited by this paper
• Teaching the immune system “self” respect and tolerance

  2014cited by this paper
• Virtual karyotyping reveals greater chromosomal stability in neural cells derived by transdifferentiation than those from stem cells.

  2014cited by this paper
• Generation of functional human pancreatic β cells in vitro.

  2014influential reference
• Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency

  2014cited by this paper
• Cell Replacement Strategies Aimed at Reconstitution of the b-Cell Compartment in Type 1

  2014influential reference
• Human somatic cell nuclear transfer using adult cells.

  2014cited by this paper
• Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease

  2014cited by this paper
• In Vivo–Generated Antigen-Specific Regulatory T Cells Treat Autoimmunity Without Compromising Antibacterial Immune Response

  2014cited by this paper
• Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering.

  2013cited by this paper
• Trials in type 1 diabetes: Antigen-specific therapies.

  2013cited by this paper
• Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo.

  2013cited by this paper
• The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

  2013cited by this paper
• Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo.

  2013cited by this paper
• Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis

  2013cited by this paper
• Cell-Based Therapeutics: The Next Pillar of Medicine

  2013cited by this paper
• Toward the development of a global induced pluripotent stem cell library.

  2013cited by this paper
• Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.

  2013cited by this paper
• Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes.

  2013cited by this paper
• Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering.

  2013cited by this paper
• Type 1 diabetes: translating mechanistic observations into effective clinical outcomes

  2013cited by this paper
• Enrichment of human embryonic stem cell‐derived NKX6.1‐expressing pancreatic progenitor cells accelerates the maturation of insulin‐secreting cells in vivo

  2013cited by this paper
• Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells

  2013cited by this paper
• iPSC-derived β cells model diabetes due to glucokinase deficiency.

  2013influential reference
• Artificial three-dimensional niches deconstruct pancreas development in vitro

  2013cited by this paper
• Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development.

  2013cited by this paper
• Generation of Functional Thymic Epithelium From Human Embryonic Stem Cells That Supports Host T Cell Development.

  2013cited by this paper
• Role of BMP Signaling in Pancreatic Progenitor Differentiation from Human Embryonic Stem Cells

  2013cited by this paper
• Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis

  2013cited by this paper
• Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency

  2013cited by this paper
• It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes

  2013cited by this paper
• Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.

  2013cited by this paper
• Human embryonic stem cells derived by somatic cell nuclear transfer.

  2013cited by this paper
• Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

  2013cited by this paper
• Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young*

  2013cited by this paper
• Cell‐based interventions to halt autoimmunity in type 1 diabetes mellitus

  2013cited by this paper
• A Model for Personalized in Vivo Analysis of Human Immune Responsiveness

  2012cited by this paper
• Expanding the Clinical Indications for α1-Antitrypsin Therapy

  2012cited by this paper
• Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche.

  2012cited by this paper
• Viral interference with antigen presentation: trapping TAP.

  2012cited by this paper
• Encapsulated islets transplantation: Past, present and future.

  2012cited by this paper
• Autologous Regulatory T Cells for the Treatment of Type 1 Diabetes

  2012cited by this paper
• The promise of induced pluripotent stem cells in research and therapy

  2012cited by this paper
• Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice

  2012cited by this paper
• Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency

  2012cited by this paper
• Human Xenografts Are Not Rejected in a Naturally Occurring Immunodeficient Porcine Line: A Human Tumor Model in Pigs

  2012cited by this paper
• Generation Of Functional Insulin-Producing Cells In The Gut By Foxo1 Ablation

  2012cited by this paper
• Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

  2012influential reference
• Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35

  2012cited by this paper
• Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.

  2012cited by this paper
• A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells

  2012cited by this paper
• Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

  2012cited by this paper
• A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation

  2012cited by this paper
• Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

  2012cited by this paper
• Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells

  2011influential reference
• DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time

  2011cited by this paper
• Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds.

  2011cited by this paper
• 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR).

  2011cited by this paper
• Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients

  2011cited by this paper
• Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

  2011cited by this paper
• Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors

  2011cited by this paper
• Review on monogenic diabetes

  2011cited by this paper
• Humanized mice for the study of type 1 and type 2 diabetes

  2011cited by this paper
• Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells.

  2011cited by this paper
• Cytokines Tumor Necrosis Factor-α and Interferon-γ Induce Pancreatic β-Cell Apoptosis through STAT1-mediated Bim Protein Activation*

  2011cited by this paper
• Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells

  2011cited by this paper
• Matrix Components and Scaffolds for Sustained Islet Function

  2011cited by this paper
• Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds.

  2011cited by this paper
• Diagnosis and management of maturity onset diabetes of the young (MODY)

  2011cited by this paper
• Etiology of type 1 diabetes

  2011cited by this paper
• Integrin {alpha}3, but not {beta}1, regulates islet cell survival and function via PI3K/Akt signaling pathways.

  2011cited by this paper
• Somatic coding mutations in human induced pluripotent stem cells

  2011cited by this paper
• Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells

  2010cited by this paper
• Etiology of type 1 diabetes.

  2010cited by this paper
• Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells.

  2010influential reference
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group

  2010cited by this paper
• Patterning of mono- and multilayered pancreatic beta-cell clusters.

  2010cited by this paper
• Islet inflammation and CXCL10 in recent‐onset type 1 diabetes

  2010cited by this paper
• Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer

  2010cited by this paper
• Generation of pluripotent stem cells from patients with type 1 diabetes

  2009cited by this paper
• Dynamic Signaling Network for the Specification of Embryonic Pancreas and Liver Progenitors

  2009cited by this paper
• Developmental biology of the pancreas: a comprehensive review.

  2009cited by this paper
• Extracellular matrix as a biological scaffold material: Structure and function.

  2009cited by this paper
• Transgenic Expression of Single-Chain Anti-CTLA-4 Fv on β Cells Protects Nonobese Diabetic Mice from Autoimmune Diabetes1

  2009cited by this paper
• Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft

  2009influential reference
• Faculty Opinions recommendation of In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

  2008cited by this paper
• Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes.

  2008cited by this paper
• Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic beta-cell differentiation in human embryonic stem cells.

  2008cited by this paper

• Recent advances of macroporous hydrogel microparticles: Fabrication and applications

  2025cites this paper
• Advanced therapy to cure diabetes: mission impossible is now possible?

  2024cites this paper
• Reduction of Activin A gives rise to comparable expression of key definitive endoderm and mature beta cell markers.

  2024cites this paper
• 2,4 -Dinitrophenol Trans-Differentiate NIH3T3 Cells into Insulin Producing β-Cells

  2024cites this paper
• Permanent neonatal diabetes-causing insulin mutations have dominant negative effects on beta cell identity

  2024cites this paper
• Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity

  2023cites this paper
• The Effect of Secretome Hypoxic Mesenchymal Stem Cells on Pro-Inflammatory and Anti-Inflammatory Markers Expression (in Vivo Experimental Study on the Macrophage Cell Polarization of Wistar Male Mice Type 1 DM Model)

  2023influential citation
• The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art

  2023cites this paper
• Permanent Neonatal diabetes-causing Insulin mutations have dominant effects on proinsulin processing and beta cell identity

  2023cites this paper
• Discrete and Continuous Glucose Monitoring Systems: The Point of View of a Patient Affected by Type-1 Diabetes

  2022cites this paper
• Maternal vitamin D status and risk of gestational diabetes mellitus: A systematic review and meta-analysis of prospective cohort studies.

  2021cites this paper
• Endocrine Pancreas Development and Dysfunction Through the Lens of Single-Cell RNA-Sequencing

  2021influential citation
• Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.

  2021cites this paper
• Generation of insulin-producing pancreatic β cells from multiple human stem cell lines

  2021cites this paper
• Challenge of diabetes mellitus and researchers’ contributions to its control

  2021influential citation
• Differentiation of human bone marrow-derived mesenchymal stem cells into functional pancreatic beta cells

  2021cites this paper
• Comparison of insulin secretion by transduced adipose-derived and endometrial-derived stem cells in 2D and 3D cultures on fibrin scaffold.

  2020cites this paper
• Human-induced pluripotent stem cells (iPSC) as a source of insulin-producing cells

  2020cites this paper
• Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.

  2020cites this paper
• Transplantation technologies for treatment of carbohydrate metabolism disorders

  2020cites this paper
• Трансплантационные технологии для лечения нарушений углеводного обмена

  2020cites this paper
• PRC2 proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Gene Expression at Promoter Regions in Euchromatin in Mice and analyzed by RNA-seq, H3K27me3 chromatin

  2019cites this paper
• The islet-expressed Lhx1 transcription factor interacts with Islet-1 and contributes to glucose homeostasis.

  2019cites this paper
• Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice.

  2019cites this paper
• Microporous scaffolds drive assembly and maturation of progenitors into β-cell clusters

  2019cites this paper
• Reprogramming Cells to Make Insulin

  2019cites this paper
• Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetes

  2019cites this paper
• A conjugation platform for CRISPR-Cas9 allows efficient β-cell engineering

  2019cites this paper
• An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy

  2019cites this paper
• Generation of insulin-secreting cells from mouse gallbladder stem cells by small molecules in vitro

  2019cites this paper
• Immunological Issues After Stem Cell-Based β Cell Replacement

  2017cites this paper
• Stem Cell-Derived Insulin-Producing β Cells to Treat Diabetes

  2017cites this paper
• High-Definition Medicine.

  2017cites this paper
• Characterization of the Human Pancreas Side Population as a Potential Reservoir of Adult Stem Cells

  2017cites this paper
• A Method of Porcine Pancreatic Islet Isolation for Microencapsulation.

  2017cites this paper
• β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells

  2017cites this paper
• Further remarks on potential implementation of the ESC and iPSC technology in clinical practice

  2017cites this paper
• Cell Therapy for Type 1 Diabetes: Current and Future Strategies

  2017cites this paper
• Caminhando para cura da Diabetes Mellitus Tipo 1

  2017cites this paper
• Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes

  2016cites this paper
• Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells

  2016cites this paper
• Co-combination of islets with bone marrow mesenchymal stem cells promotes angiogenesis.

  2016cites this paper
• miR-145 modulates lncRNA-ROR and Sox2 expression to maintain human amniotic epithelial stem cell pluripotency and β islet-like cell differentiation efficiency.

  2016cites this paper
• Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation.

  2016cites this paper
• β-cell replacement sources for type 1 diabetes: a focus on pancreatic ductal cells

  2016cites this paper
• Role for cell-to-cell communication in stem cell specification toward pancreatic progenitors: relevance to the design of novel therapies for diabetes.

  2016cites this paper
• A study of the role of GATA6 in definitive endoderm specification and beta cell functionality by genome engineering of pluripotent stem cells

  2016cites this paper
• Cell-based Therapy for Treatment of Diabetes Mellitus: Can the Agonists of Growth Hormone-releasing Hormone Make a Contribution?

  2016cites this paper
• A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials

  2016cites this paper
• The Artificial Pancreas: A Dynamic Challenge

  2016cites this paper
• Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method

  2016cites this paper
• Interplay between mitochondria, primary cilium, diabetes and its complications

  2016cites this paper
• Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.

  2015cites this paper
• Dissecting Long-Term Glucose Metabolism Identifies New Susceptibility Period for Metabolic Dysfunction in Aged Mice

  2015cites this paper